Literature DB >> 34477485

Damage-associated Molecular Patterns in Clinical and Animal Models of Uveitis.

Henry J Kaplan1, Deming Sun2, Hui Shao3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34477485      PMCID： PMC8891391          DOI： 10.1080/09273948.2021.1954203

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN： 0927-3948            Impact factor:   3.728


× No keyword cloud information.
  72 in total

1.  The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.

Authors:  Karin Loser; Thomas Vogl; Maik Voskort; Aloys Lueken; Verena Kupas; Wolfgang Nacken; Lars Klenner; Annegret Kuhn; Dirk Foell; Lydia Sorokin; Thomas A Luger; Johannes Roth; Stefan Beissert
Journal:  Nat Med       Date:  2010-05-09       Impact factor: 53.440

Review 2.  Insight into the mechanisms regulating immune homeostasis in health and disease.

Authors:  Stitaya Sirisinha
Journal:  Asian Pac J Allergy Immunol       Date:  2011-03       Impact factor: 2.310

3.  CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells.

Authors:  P Esser; K Heimann; H Abts; A Fontana; M Weller
Journal:  Biochem Biophys Res Commun       Date:  1995-08-24       Impact factor: 3.575

4.  Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.

Authors:  Steven T Leach; Zheng Yang; Isabella Messina; Changjie Song; Carolyn L Geczy; Anne M Cunningham; Andrew S Day
Journal:  Scand J Gastroenterol       Date:  2007-11       Impact factor: 2.423

5.  The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate.

Authors:  K-Y Chung; J-J Park; Y S Kim
Journal:  Transplant Proc       Date:  2008-09       Impact factor: 1.066

6.  S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome.

Authors:  Lin Wang; Carlos D Rosé; Kevin P Foley; Jordi Anton; Brigitte Bader-Meunier; Philippe Brissaud; Gaelle Chédeville; Rolando Cimaz; Jorge Fernández-Martín; Catherine Guly; Eric Hachulla; Miroslav Harjacek; Friederike Mackensen; Rosa Merino; Consuelo Modesto; Antonio Naranjo Hernández; Christine Pajot; Athimalaipet V Ramanan; Akaluck Thatayatikom; Caroline Thomée; Sebastiaan Vastert; Bart J Votta; John Bertin; Carine H Wouters
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

7.  Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.

Authors:  Jane Tian; Ana Maria Avalos; Su-Yau Mao; Bo Chen; Kannaki Senthil; Herren Wu; Peggy Parroche; Stacey Drabic; Douglas Golenbock; Cherilyn Sirois; Jing Hua; Ling Ling An; Laurent Audoly; Greg La Rosa; Angelika Bierhaus; Peter Naworth; Ann Marshak-Rothstein; Mary K Crow; Katherine A Fitzgerald; Eicke Latz; Peter A Kiener; Anthony J Coyle
Journal:  Nat Immunol       Date:  2007-04-08       Impact factor: 25.606

8.  Phenotype of Innate Immune Cells in Uveitis Associated with Axial Spondyloarthritis- and Juvenile Idiopathic Arthritis-associated Uveitis.

Authors:  Maren Kasper; Karoline Walscheid; Björn Laffer; Dirk Bauer; Martin Busch; Karin Loser; Thomas Vogl; Thomas Langmann; Gerd Ganser; Thomas Rath; Arnd Heiligenhaus
Journal:  Ocul Immunol Inflamm       Date:  2020-03-11       Impact factor: 3.070

Review 9.  HMGB1: endogenous danger signaling.

Authors:  John R Klune; Rajeev Dhupar; Jon Cardinal; Timothy R Billiar; Allan Tsung
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

10.  Leukocyte toll-like receptor expression in pathergy positive and negative Behçet's disease patients.

Authors:  Tim B van der Houwen; Willem A Dik; Marco Goeijenbier; Manizhah Hayat; Nicole M A Nagtzaam; Martin van Hagen; Jan A M van Laar
Journal:  Rheumatology (Oxford)       Date:  2020-12-01       Impact factor: 7.580
View more
  1 in total

Review 1.  Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.

Authors:  Binapani Mahaling; Shermaine W Y Low; Molly Beck; Devesh Kumar; Simrah Ahmed; Thomas B Connor; Baseer Ahmad; Shyam S Chaurasia
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.